MedTrace Logo

Molecular Genetic Mechanisms of Infantile Epilepsies and the Impact of Genetic Diagnosis

NCT06701084 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2026-04-27

No results posted yet for this study

Summary

The goal of this study is to discover new genetic causes of infantile epilepsies and evaluate the impact of these discoveries on infants with epilepsy and their families.

Conditions

  • Neonatal Epilepsy
  • Infantile Epilepsy

Interventions

GENETIC

Genomic Sequencing

Genomic sequencing data will be comprehensively analyzed for pathogenic variants that explain the participants epilepsy.

Sponsors & Collaborators

Principal Investigators

  • Alissa M D'Gama, MD, PhD · Boston Children's Hospital

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-02
Primary Completion
2029-11-30
Completion
2029-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06701084 on ClinicalTrials.gov